Research output per year
Research output per year
Fingerprint
Dive into the research topics where Microbiology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Adolfo Garcia-Sastre
- Cancer Immunology
- Genetics and Genomic Sciences
- Graduate School of Biomedical Sciences
- Icahn Genomics Institute
- Icahn School of Medicine at Mount Sinai
- Medicine
- Medicine - Infectious Diseases
- Microbiology
- Mount Sinai Global Health and Emerging Pathogens Institute
- The Tisch Cancer Institute
Person
Research output
-
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
El Sahly, H. M., Anderson, E. J., Jackson, L. A., Neuzil, K. M., Atmar, R. L., Bernstein, D. I., Chen, W. H., Creech, C. B., Frey, S. E., Goepfert, P., Meier, J., Phadke, V., Rouphael, N., Rupp, R., Stapleton, J. T., Spearman, P., Walter, E. B., Winokur, P. L., Yildirim, I. & Williams, T. L. & 10 others, , 15 Feb 2025, In: Vaccine. 47, 126689.Research output: Contribution to journal › Article › peer-review
-
A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge
Slamanig, S., Lemus, N., Lai, T. Y., Singh, G., Mishra, M., Abdeljawad, A., Boza, M., Dolange, V., Singh, G., Lee, B., González-Domínguez, I., Schotsaert, M., Krammer, F., Palese, P. & Sun, W., 25 Jan 2025, In: Vaccine. 45, 126586.Research output: Contribution to journal › Article › peer-review
-
-
N-arylpyrimidinamine (NAPA) compounds are broadly acting inhibitors of human cytomegalovirus infection and spread
Atanasoff, K. E., Ophir, S. I., Parsons, A. J., Paredes Casado, J., Lurain, N. S., Bowlin, T. L., Opperman, T. J. & Tortorella, D., Jan 2025, In: Antiviral Research. 233, 106044.Research output: Contribution to journal › Article › peer-review
-
Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico
López-Macías, C., Torres, M., Armenta-Copca, B., Wacher, N. H., Castro-Castrezana, L., Colli-Domínguez, A. A., Rivera-Hernández, T., Torres-Flores, A., Damián-Hernández, M., Ramírez-Martínez, L., la Rosa, G. P. D., Rojas-Martínez, O., Suárez-Martínez, A., Peralta-Sánchez, G., Carranza, C., Juárez, E., Zamudio-Meza, H., Carreto-Binaghi, L. E., Viettri, M. & Romero-Rodríguez, D. & 11 others, , 1 Jan 2025, In: Vaccine. 43, 126511.Research output: Contribution to journal › Article › peer-review
Open Access -
PhosNetVis: A web-based tool for fast kinase-substrate enrichment analysis and interactive 2D/3D network visualizations of phosphoproteomics data
Rawal, O., Turhan, B., Peradejordi, I. F., Chandrasekar, S., Kalayci, S., Gnjatic, S., Johnson, J., Bouhaddou, M. & Gümüş, Z. H., 10 Jan 2025, In: Patterns. 6, 1, 101148.Research output: Contribution to journal › Article › peer-review
Open Access -
Proteomic signatures of vaccine-induced and breakthrough infection-induced host responses to SARS-CoV-2
Williams, E., Echeverri Tribin, F., Carreño, J. M., Krammer, F., Hoffer, M., Pallikkuth, S. & Pahwa, S., 1 Jan 2025, In: Vaccine. 43, 126484.Research output: Contribution to journal › Article › peer-review
-
Replication kinetics, pathogenicity and virus-induced cellular responses of cattle-origin influenza A(H5N1) isolates from Texas, United States
Mostafa, A., Barre, R. S., Allué-Guardia, A., Escobedo, R. A., Shivanna, V., Rothan, H., Castro, E. M., Ma, Y., Cupic, A., Jackson, N., Bayoumi, M., Torrelles, J. B., Ye, C., García-Sastre, A. & Martinez-Sobrido, L., 2025, In: Emerging Microbes and Infections. 14, 1, 2447614.Research output: Contribution to journal › Article › peer-review
Open Access -
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial
Thiem, V. D., Anh, D. D., Ha, V. H., Van Thom, N., Thang, T. C., Mateus, J., Carreño, J. M., Raghunandan, R., Huong, N. M., Mercer, L. D., Flores, J., Escarrega, E. A., Raskin, A., Thai, D. H., Van Be, L., Sette, A., Innis, B. L., Krammer, F. & Weiskopf, D., 12 Jan 2025, In: Vaccine. 44, 126542.Research output: Contribution to journal › Article › peer-review
Open Access -
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans
Cortese, M., Hagan, T., Rouphael, N., Wu, S. Y., Xie, X., Kazmin, D., Wimmers, F., Gupta, S., van der Most, R., Coccia, M., Aranuchalam, P. S., Nakaya, H. I., Wang, Y., Coyle, E., Horiuchi, S., Wu, H., Bower, M., Mehta, A., Gunthel, C. & Bosinger, S. E. & 13 others, , Jan 2025, In: Nature Immunology. 26, 1, p. 116-130 15 p., eabb1025.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
ACE2 and TMPRSS2 distribution in the respiratory tract of different animal species and its correlation with SARS-CoV-2 tissue tropism
Carossino, M., Izadmehr, S., Trujillo, J. D., Gaudreault, N. N., Dittmar, W., Morozov, I., Balasuriya, U. B. R., Cordon-Cardo, C., García-Sastre, A. & Richt, J. A., Feb 2024, In: Microbiology spectrum. 12, 2Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein
Bliss, C. M., Nachbagauer, R., Mariottini, C., Cuevas, F., Feser, J., Naficy, A., Bernstein, D. I., Guptill, J., Walter, E. B., Berlanda-Scorza, F., Innis, B. L., García-Sastre, A., Palese, P., Krammer, F. & Coughlan, L., Jun 2024, In: eBioMedicine. 104, 105153.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations
Press/Media
-
Reports from Icahn School of Medicine at Mount Sinai Highlight Recent Research in COVID-19 (A surrogate ELISA to select high titer human convalescent plasma for treating immunocompromised patients infected with SARS-CoV-2 variants of concern)
Krammer, F., Palese, P., Simon, V. & Sun, W.
17/01/25
1 item of Media coverage
Press/Media
-
Wrong place, wrong time: Why Zika virus hijacks a protein needed for brain growth
15/01/25
1 item of Media coverage
Press/Media
-
-UC Davis - Wrong place, wrong time, why Zika virus hijacks a protein needed for brain growth
15/01/25
2 items of Media coverage
Press/Media
-
Press Conference Launches Ignaz Semmelweis Institute: A New Era in Healthcare Innovation
Krammer, F.
14/01/25
1 item of Media coverage
Press/Media
-
Wrong place, wrong time: Why Zika virus hijacks a protein needed for brain growth
14/01/25
1 item of Media coverage
Press/Media
-
WRONG PLACE, WRONG TIME; Why Zika virus hijacks a protein needed for brain growth
14/01/25
1 item of Media coverage
Press/Media
-
HMN 2025: Wrong place, unsuitable time: Why the Zika virus hijacks a protein wanted for mind development
13/01/25
1 item of Media coverage
Press/Media
-
Wrong Place, Wrong Time: Why Zika Virus Hijacks a Protein Needed for Brain Growth
13/01/25
5 items of Media coverage
Press/Media
-
HMN 2025: Wrong place, wrong time: Why the Zika virus hijacks a protein needed for brain growth
13/01/25
1 item of Media coverage
Press/Media
-
Study Data from University of Miami Update Understanding of COVID-19 (Proteomic Signatures of Vaccine-induced and Breakthrough Infection-induced Host Responses To Sars-cov-2)
Krammer, F.
6/01/25
1 item of Media coverage
Press/Media